Asset Dedication LLC’s Takeda Pharmaceutical TAK Stock Holding History

Asset Dedication LLC’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-186	Closed	-$3K	–	935
2022 Q1	$3K	Hold	186	–	–	﹤0.01%	836
2021 Q4	$3K	Hold	186	–	–	﹤0.01%	823
2021 Q3	$3K	Hold	186	–	–	﹤0.01%	883
2021 Q2	$3K	Buy	+186	New	+$3.17K	﹤0.01%	767
2021 Q1	–	Sell	-186	Closed	-$3K	–	773
2020 Q4	$3K	Hold	186	–	–	﹤0.01%	683
2020 Q3	$3K	Buy	+186	New	+$3.39K	﹤0.01%	655

Other funds holding TAK

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Asset Dedication LLC's TAK Position: Q2 2022 in Review

Asset Dedication LLC sold out of Takeda Pharmaceutical (TAK) in Q2 2022, closing a stake of 186 shares — an estimated $3K sold.

Asset Dedication LLC first reported a position in TAK in Q3 2020 and held it in 6 quarters. The position peaked at $3K in Q1 2022. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

Asset Dedication LLC reported no remaining Takeda Pharmaceutical position as of Q2 2022 after selling out during the quarter.
Asset Dedication LLC sold 186 Takeda Pharmaceutical shares in Q2 2022, an estimated $3K.
Asset Dedication LLC first reported a position in Takeda Pharmaceutical in Q3 2020 and held it in 6 quarters.
Asset Dedication LLC's Takeda Pharmaceutical position peaked at $3K in Q1 2022.
283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on Asset Dedication LLC's 13F filing for Q2 2022, filed 19 Jul 2022.